Organ-on-a-Chip & Organoids Event 2025

Health~Holland, Utrecht Science Park and the Netherlands Enterprise Agency, are excited to announce their upcoming Organ-on-a-Chip and Organoids event, Thursday 28 August at Utrecht Science Park (Utrecht, the Netherlands).

All stakeholders active in Organ-on-a-Chip technology and Organoids are invited to participate in this event. This includes not only academic and technological partners but also end-users such as CROs and pharmaceutical companies, as well as all relevant disciplines, reflecting the inherently interdisciplinary nature of this field.

Organ-on-a-Chip & Organoid technology is paving the way for the future of biomedical innovation. With its potential to revolutionize healthcare, accelerate drug development, and personalize treatment like never before, this field is rapidly capturing global attention. But innovation alone won’t drive change. Successful implementation demands international collaboration involving public and private stakeholders on science, business and regulations. That means uniting our expertise, exchanging insights, and forging strong international partnerships. By working together, we can position ourselves as global leaders in this transformative domain. And that’s exactly the spirit that will be brought to life on 28 August 2025.

This event is organised in the context of Health~Holland’s Organ-on-Chip initiative and is linked to the R&D call.

Program 12:00h – 18:00h

(Outlines of the program, exact program will be announced shortly)

Start event

Walk-in and networking lunch

Introductory speech

By Carmen van Vilsteren, Chair Top Sector Life Sciences & Health (Health~Holland)

Presentation Interconnected ecosystem in the Netherlands & H~H Organ-on-Chip call

By Laura Windt, Health~Holland

Insights from Key Players in the Dutch ecosystem

hDMT – Hanna Lammertse

NXTGEN Hightech – Massimo Mastrangeli

B/MSC – TBD

Ombion: Closing the gap between development of animal-free technologies and regulatory application: an innovation systems perspective – Anne Kienhuis

Keynote: Patient-derived in vitro models: from bench to clinical application

By Jeffrey Beekman, Professor Cellular Disease Models at University Medical Center Utrecht

Presentation Mimetas

Developer and manufacturer of Organ-on-Chip models, TBC

From Bench to Impact: An Academic Journey in Organoid Technology

By Bart Spee, Associate Professor at Utrecht University, Co-founder and CTO Orgonex

Panel discussion

Organ-on-chip and Organoid implementation through collaboration with end-users: Merck, Mimetas (TBC)

Pitches

As part of the program, we offered organisations the opportunity to pitch their product, innovation, offering or collaboration idea. Due to the high number of people interested in pitching and limited available time slots, registration for pitches is now officially closed. We’ve reached full capacity and are no longer able to accept additional presenters.

If you were hoping to pitch but missed the deadline, or were not allocated a slot due to maximum capacity, rest assured there will be future opportunities to share your ideas and connect with potential collaborators.

Networking drinks and speed dating

18:00h End program

Welcome to join!

In order to join this event, the organisers request all interested to register on this online B2match platform. After registration you will be updated about program development and pitching options.

Register here

Please note: This event has a limited number of spots available. Once full, registration will close, so be sure to sign up early.

Besides registration for this physical event in Utrecht (the Netherlands), The platform offers an online marketplace and matchmaking tool where project ideas, cooperation offers, and requests can be shared, with the aim of identifying synergies, forming clusters, and selecting and integrating promising initiatives. This interactive platform serves as the starting point for collaboration.

This event will be organized as part of a strategic collaboration commissioned by the Dutch Ministry of Economic Affairs, in partnership with Health~Holland, the Netherlands Enterprise Agency (RVO), the Dutch Embassy in Switzerland, and stakeholders from the life sciences & health sector. More about this collaboration, see: H~H Organ-on-Chip initiative.